{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:17:13Z","timestamp":1795220233095,"version":"4.10.3"},"reference-count":259,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.pap.0000175117.47918.f7","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T04:01:25Z","timestamp":1123646485000},"page":"180-194","source":"Crossref","is-referenced-by-count":46,"title":["Molecular Diagnostics in Central Nervous System Tumors"],"prefix":"10.1097","volume":"12","author":[{"given":"Christine E","family":"Fuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.LAB.0000059948.67795.EF","article-title":"Molecular diagnosis of oligodendroglioma in paraffin sections.","volume":"83","author":"Hatanpaa","year":"2003","journal-title":"Lab Invest"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9440(10)64076-X","article-title":"Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.","volume":"158","author":"Nigro","year":"2001","journal-title":"Am J Pathol"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3171\/jns.1994.81.3.0427","article-title":"Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.","volume":"81","author":"Lang","year":"1994","journal-title":"J Neurosurg"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/glia.440150312","article-title":"Molecular pathways in the formation of gliomas.","volume":"15","author":"von Deimling","year":"1995","journal-title":"Glia"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1750-3639.1996.tb00848.x","article-title":"Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.","volume":"6","author":"Watanabe","year":"1996","journal-title":"Brain Pathol"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnen\/61.4.321","article-title":"Impact of genotype and morphology on the prognosis of glioblastoma.","volume":"61","author":"Schmidt","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R8-2-20210202","first-page":"180","article-title":"Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.","volume":"8","author":"Burton","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cncr.20432","article-title":"Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization grade II astrocytoma or oligoastrocytoma.","volume":"101","author":"Stander","year":"2004","journal-title":"Cancer"},{"key":"R10-2-20210202","first-page":"607","article-title":"Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.","volume":"14","author":"Hwang","year":"1998","journal-title":"Kaohsiung J Med Sci"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1750-3639.1998.tb00191.x","article-title":"Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.","volume":"8","author":"Newcomb","year":"1998","journal-title":"Brain Pathol"},{"key":"R12-2-20210202","first-page":"1122","article-title":"Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.","volume":"61","author":"Simmons","year":"2001","journal-title":"Cancer Res"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/93.16.1246","article-title":"PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.","volume":"93","author":"Smith","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/gcc.10029","article-title":"Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.","volume":"33","author":"Wessels","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"R15-2-20210202","first-page":"7683","article-title":"Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.","volume":"61","author":"Kunwar","year":"2001","journal-title":"Cancer Res"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jso.20036","article-title":"EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas.","volume":"86","author":"Varela","year":"2004","journal-title":"J Surg Oncol"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/jnen\/60.11.1099","article-title":"Small cell architecture- a histological equivalent of EGFR amplification in glioblastoma multiforme?","volume":"60","author":"Burger","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/cncr.20625","article-title":"Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.","volume":"101","author":"Perry","year":"2004","journal-title":"Cancer"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1016218117251","article-title":"Immunohistochemical markers for prognosis of cerebral glioblastoma.","volume":"58","author":"Korshunov","year":"2002","journal-title":"J Neurooncol"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnen\/63.7.700","article-title":"Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.","volume":"63","author":"Aldape","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R21-2-20210202","first-page":"6962","article-title":"Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.","volume":"63","author":"Shinojima","year":"2003","journal-title":"Cancer Res"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-004-0875-6","article-title":"Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.","volume":"108","author":"Andersson","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2741\/Smith","article-title":"Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications.","volume":"5","author":"Smith","year":"2000","journal-title":"Front Biosci"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1006420921159","article-title":"Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor.","volume":"48","author":"Cianciulli","year":"2000","journal-title":"J Neurooncol"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ajcp\/108.2.166","article-title":"Interphase cytogenetics (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy.","volume":"108","author":"Perry","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"R26-2-20210202","first-page":"6205","article-title":"Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.","volume":"62","author":"Burton","year":"2002","journal-title":"Cancer Res"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10143-003-0279-4","article-title":"The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.","volume":"27","author":"Arslantas","year":"2004","journal-title":"Neurosurg Rev"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/1097-0142(19940801)74:3<920::AID-CNCR2820740320>3.0.CO;2-4","article-title":"Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers.","volume":"74","author":"Ganju","year":"1994","journal-title":"Cancer"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1440-1827.1999.00934.x","article-title":"Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis.","volume":"49","author":"Horiguchi","year":"1999","journal-title":"Pathol Int"},{"key":"R30-2-20210202","first-page":"96","article-title":"Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.","volume":"6","author":"Brat","year":"2004","journal-title":"Neurooncol"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00005072-199911000-00007","article-title":"Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.","volume":"58","author":"Schmidt","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<150::AID-IJC10>3.0.CO;2-#","article-title":"Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.","volume":"84","author":"Zhou","year":"1999","journal-title":"Int J Cancer"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jnen\/61.12.1078","article-title":"High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).","volume":"61","author":"Fuller","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R34-2-20210202","first-page":"1790","article-title":"DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.","volume":"62","author":"Sasaki","year":"2002","journal-title":"Cancer Res"},{"key":"R35-2-20210202","first-page":"2447","article-title":"Allelic deletion analyses of MMAC\/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.","volume":"4","author":"Lin","year":"1998","journal-title":"Clin Cancer Res"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1016261900413","article-title":"Immunohistochemical markers for prognosis of anaplastic astrocytomas.","volume":"58","author":"Korshunov","year":"2002","journal-title":"J Neurooncol"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3171\/jns.2003.99.5.0886","article-title":"Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.","volume":"99","author":"Hung","year":"2003","journal-title":"J Neurosurg"},{"key":"R38-2-20210202","first-page":"6321","article-title":"CDKN2 (p16\/MTS1) gene deletion of CDK4 amplification occurs in the majority of glioblastomas.","volume":"54","author":"Schmidt","year":"1994","journal-title":"Cancer Res"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1006185220369","article-title":"CDKN2\/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.","volume":"41","author":"Miettinen","year":"1999","journal-title":"J Neurooncol"},{"key":"R40-2-20210202","first-page":"551","article-title":"Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.","volume":"5","author":"Mizumatsu","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00005072-199702000-00009","article-title":"Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.","volume":"56","author":"Biernat","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s004010050711","article-title":"Alteration of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.","volume":"94","author":"Biernat","year":"1997","journal-title":"Acta Neuropathol (Berl)"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcp\/112.6.801","article-title":"Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.","volume":"112","author":"Perry","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R44-2-20210202","first-page":"150","article-title":"CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.","volume":"56","author":"Ueki","year":"1996","journal-title":"Cancer Res"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1006473320474","article-title":"Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and pRB, and Ki-67 labeling in high grade astrocytomas treated with radiotherapy.","volume":"46","author":"Kirla","year":"2000","journal-title":"J Neurooncol"},{"key":"R46-2-20210202","first-page":"501","article-title":"Alteration of CDKN2\/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents.","volume":"17","author":"Iwadate","year":"2000","journal-title":"Int J Oncol"},{"key":"R47-2-20210202","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/bjc.1997.216","article-title":"MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.","volume":"75","author":"Korkolopoulou","year":"1997","journal-title":"Br J Cancer"},{"key":"R48-2-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1005841520514","article-title":"Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.","volume":"35","author":"Rainov","year":"1997","journal-title":"J Neurooncol"},{"key":"R49-2-20210202","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/cncr.11079","article-title":"Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.","volume":"97","author":"Kirla","year":"2003","journal-title":"Cancer"},{"key":"R50-2-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(97)00688-5","article-title":"p27\/kip1 expression in human astrocytic gliomas.","volume":"234","author":"Piva","year":"1997","journal-title":"Neurosci Lett"},{"key":"R51-2-20210202","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004010000261","article-title":"High cyclin E\/low p27Kip1 expression is associated with poor prognosis in astrocytomas.","volume":"101","author":"Tamiya","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"R52-2-20210202","first-page":"4277","article-title":"Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.","volume":"52","author":"von Deimling","year":"1992","journal-title":"Cancer Res"},{"key":"R53-2-20210202","first-page":"1397","article-title":"Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.","volume":"54","author":"von Deimling","year":"1992","journal-title":"Cancer Res"},{"key":"R54-2-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1007>3.0.CO;2-I","article-title":"Mapping of the chromosome 19q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.","volume":"29","author":"Smith","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3171\/jns.1998.88.3.0513","article-title":"Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low grade astrocytoma.","volume":"88","author":"Abdulrauf","year":"1998","journal-title":"J Neurosurg"},{"key":"R56-2-20210202","first-page":"335","article-title":"Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.","volume":"140","author":"Dietzmann","year":"1994","journal-title":"Zentralbl Pathol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1996.107","article-title":"c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.","volume":"73","author":"Haapasalo","year":"1996","journal-title":"Br J Cancer"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01324695","article-title":"Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu\/erbB2 expression in glioblastomas (GBMs).","volume":"16","author":"Hiesiger","year":"1993","journal-title":"J Neurooncol"},{"key":"R59-2-20210202","first-page":"417","article-title":"Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors.","volume":"13","author":"Hwang","year":"1997","journal-title":"Kaohsiung J Med Sci"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.COC.0000020922.66984.E7","article-title":"Role of her-2\/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme.","volume":"26","author":"Koka","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"R61-2-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/JMN:13:1-2:177","article-title":"Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas.","volume":"13","author":"Lafuente","year":"1999","journal-title":"J Mol Neurosci"},{"key":"R62-2-20210202","first-page":"863","article-title":"Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance.","volume":"11","author":"Nam","year":"2004","journal-title":"Oncol Rep"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006333005563","article-title":"Vascular endothelial growth factor (VEGF) in astrocytic gliomas- a prognostic factor?","volume":"45","author":"Oehring","year":"1999","journal-title":"J Neurooncol"},{"key":"R64-2-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s007010170122","article-title":"Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.","volume":"143","author":"Yao","year":"2001","journal-title":"Acta Neurochir (Wien)"},{"key":"R65-2-20210202","first-page":"1005","article-title":"Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.","volume":"51","author":"Eller","year":"2002","journal-title":"Neurosurgery"},{"key":"R66-2-20210202","first-page":"3154","article-title":"Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.","volume":"63","author":"Mamot","year":"2003","journal-title":"Cancer Res"},{"key":"R67-2-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/jns.2004.101.3.0505","article-title":"Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27.","volume":"101","author":"Park","year":"2004","journal-title":"J Neurosurg"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-4608(94)00123-S","article-title":"Chromosomal abnormalities in 47 pediatric brain tumors.","volume":"81","author":"Agamanolis","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"R69-2-20210202","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00043426-199711000-00002","article-title":"Genetics of pediatric central nervous system tumors.","volume":"19","author":"Biegel","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"R70-2-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00005072-199756070-00004","article-title":"Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.","volume":"56","author":"Sure","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R71-2-20210202","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0046-8177(99)90057-6","article-title":"Genetic alterations in pediatric high-grade astrocytomas.","volume":"30","author":"Cheng","year":"1999","journal-title":"Hum Pathol"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00250194","article-title":"Molecular biology of pediatric gliomas.","volume":"28","author":"Raffel","year":"1996","journal-title":"J Neurooncol"},{"key":"R73-2-20210202","first-page":"4085","article-title":"Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.","volume":"5","author":"Raffel","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R74-2-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-3639.2000.tb00258.x","article-title":"Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.","volume":"10","author":"Sung","year":"2000","journal-title":"Brain Pathol"},{"key":"R75-2-20210202","first-page":"1786","article-title":"Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.","volume":"5","author":"Bredel","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R76-2-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1019697117253","article-title":"Molecular genetic changes in a series of neuroepithelial tumors of childhood.","volume":"59","author":"DiSapio","year":"2002","journal-title":"J Neurooncol"},{"key":"R77-2-20210202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2002.00413.x","article-title":"Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4, and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.","volume":"28","author":"Kraus","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R78-2-20210202","first-page":"304","article-title":"The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.","volume":"57","author":"Pollack","year":"1997","journal-title":"Cancer Res"},{"key":"R79-2-20210202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJMoa012224","article-title":"Expression of p53 and prognosis in children with malignant gliomas.","volume":"346","author":"Pollack","year":"2002","journal-title":"N Engl J Med"},{"key":"R80-2-20210202","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2559.2000.01005.x","article-title":"Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.","volume":"37","author":"Cheng","year":"2000","journal-title":"Histopathology"},{"key":"R81-2-20210202","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1054\/bjoc.1999.1066","article-title":"Analysis of pilocytic astrocytoma by comparative genomic hybridization.","volume":"82","author":"Sanoudou","year":"2000","journal-title":"Br J Cancer"},{"key":"R82-2-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2990.2000.00258.x","article-title":"Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.","volume":"26","author":"Gutmann","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R83-2-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.56.7.885","article-title":"Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.","volume":"56","author":"Li","year":"2001","journal-title":"Neurology"},{"key":"R84-2-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s100480100116","article-title":"Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma.","volume":"3","author":"Giannini","year":"2001","journal-title":"Neurogenetics"},{"key":"R85-2-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(01)00512-X","article-title":"Genetic imbalances in pleomorphic xanthoastrocytoma detected by comparative genomic hybridization and literature review.","volume":"132","author":"Yin","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"R86-2-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s004010050428","article-title":"Molecular genetic alterations in pleomorphic xanthoastrocytoma.","volume":"91","author":"Paulus","year":"1996","journal-title":"Acta Neuropathol (Berl)"},{"key":"R87-2-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/srao.2001.21412","article-title":"Pathology of low- and intermediate-grade gliomas.","volume":"11","author":"Fuller","year":"2001","journal-title":"Semin Radiat Oncol"},{"key":"R88-2-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1005715703598","article-title":"Supratentorial gliomas: a comparative study by grade and histologic type.","volume":"31","author":"Shaw","year":"1997","journal-title":"J Neurooncol"},{"key":"R89-2-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ana.410230408","article-title":"Successful chemotherapy for recurrent malignant oligodendroglioma.","volume":"23","author":"Cairncross","year":"1988","journal-title":"Ann Neurol"},{"key":"R90-2-20210202","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00006123-199912000-00001","article-title":"Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.","volume":"45","author":"Fortin","year":"1999","journal-title":"Neurosurgery"},{"key":"R91-2-20210202","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3171\/jns.1992.76.5.0741","article-title":"The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.","volume":"76","author":"Glass","year":"1992","journal-title":"J Neurosurg"},{"key":"R92-2-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00005072-199501000-00011","article-title":"Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.","volume":"54","author":"Kraus","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"R93-2-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00125480-200107000-00001","article-title":"Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.","volume":"8","author":"Perry","year":"2001","journal-title":"Adv Anat Pathol"},{"key":"R94-2-20210202","doi-asserted-by":"crossref","first-page":"a1","DOI":"10.2741\/896","article-title":"Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.","volume":"8","author":"Perry","year":"2003","journal-title":"Front Biosci"},{"key":"R95-2-20210202","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol"},{"key":"R96-2-20210202","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1038\/sj.onc.1202759","article-title":"Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.","volume":"18","author":"Smith","year":"1999","journal-title":"Oncogene"},{"key":"R97-2-20210202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R98-2-20210202","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"R99-2-20210202","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0360-3016(00)00703-3","article-title":"Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.","volume":"48","author":"Bauman","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R100-2-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1022580610598","article-title":"Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.","volume":"61","author":"Chahlavi","year":"2003","journal-title":"J Neurooncol"},{"key":"R101-2-20210202","first-page":"196","article-title":"Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.","volume":"8","author":"Ueki","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R102-2-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s004010100464","article-title":"Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.","volume":"103","author":"Watanabe","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"R103-2-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnen\/61.1.58","article-title":"Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade oligodendroglioma.","volume":"61","author":"Sasaki","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R104-2-20210202","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.11187","article-title":"Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.","volume":"97","author":"van den Bent","year":"2003","journal-title":"Cancer"},{"key":"R105-2-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1750-3639.2004.tb00044.x","article-title":"Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival.","volume":"14","author":"Felsberg","year":"2004","journal-title":"Brain Pathol"},{"key":"R106-2-20210202","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/cncr.11322","article-title":"Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.","volume":"97","author":"Hashimoto","year":"2003","journal-title":"Cancer"},{"key":"R107-2-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/gcc.2870120407","article-title":"Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.","volume":"12","author":"Ritland","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"R108-2-20210202","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnen\/62.11.1118","article-title":"Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial\/astrocytic features.","volume":"62","author":"Fuller","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"R109-2-20210202","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.5858\/2003-127-1573-ALIOAO","article-title":"Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms.","volume":"127","author":"Johnson","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R110-2-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1309\/KLAG-TARW-WDBJ-5CTJ","article-title":"Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors.","volume":"118","author":"Prayson","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R111-2-20210202","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/cncr.11783","article-title":"Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.","volume":"98","author":"Fouladi","year":"2003","journal-title":"Cancer"},{"key":"R112-2-20210202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/jnen\/61.11.947","article-title":"Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.","volume":"61","author":"Perry","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R113-2-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.2870090107","article-title":"Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas.","volume":"9","author":"Bello","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"R114-2-20210202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65134-6","article-title":"Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.","volume":"155","author":"Bigner","year":"1999","journal-title":"Am J Pathol"},{"key":"R115-2-20210202","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.57.7.1278","article-title":"Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.","volume":"57","author":"Hoang-Xuan","year":"2001","journal-title":"Neurology"},{"key":"R116-2-20210202","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3171\/jns.2002.97.6.1397","article-title":"Analysis of loss of chromosome 10q, DMBT1 homozygous deletions and PTEN mutations in oligodendrogliomas.","volume":"97","author":"Sanson","year":"2002","journal-title":"J Neurosurg"},{"key":"R117-2-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1025689004046","article-title":"Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.","volume":"64","author":"Thiessen","year":"2003","journal-title":"J Neurooncol"},{"key":"R118-2-20210202","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/1097-0215(20001115)88:4<554::AID-IJC6>3.0.CO;2-Q","article-title":"CDKN2A\/p16 inactivation in the prognosis of oligodendrogliomas.","volume":"88","author":"Bortolotto","year":"2000","journal-title":"Int J Cancer"},{"key":"R119-2-20210202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-4608(99)00210-1","article-title":"PTEN mutation analysis in two genetic subtypes of high-grade oligodendroglial tumors: PTEN is only occasionally mutated in one of the two genetic subtypes.","volume":"119","author":"Jeuken","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"R120-2-20210202","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9440(10)61702-6","article-title":"PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.","volume":"159","author":"Sasaki","year":"2001","journal-title":"Am J Pathol"},{"key":"R121-2-20210202","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s004010051128","article-title":"p27\/kip1 expression in oligodendrogliomas and its possible prognostic role.","volume":"98","author":"Cavalla","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"R122-2-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1016270101321","article-title":"Immunohistochemical markers for prognosis of oligodendroglial neoplasms.","volume":"58","author":"Korshunov","year":"2002","journal-title":"J Neurooncol"},{"key":"R123-2-20210202","doi-asserted-by":"crossref","first-page":"892","DOI":"10.5858\/2001-125-0892-TPSODT","article-title":"The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21\/Cip-1, and p27\/Kip-1 protein immunoexpression in oligodendrogliomas.","volume":"125","author":"Korshunov","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R124-2-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2990.2000.00263.x","article-title":"Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.","volume":"26","author":"Varlet","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R125-2-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1006475312401","article-title":"The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.","volume":"48","author":"Korshunov","year":"2000","journal-title":"J Neurooncol"},{"key":"R126-2-20210202","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnen\/63.4.314","article-title":"Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.","volume":"63","author":"Fallon","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R127-2-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnen\/62.5.530","article-title":"Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.","volume":"62","author":"Raghavan","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"R128-2-20210202","first-page":"552","article-title":"Molecular characterization of pediatric oligodendroglial neoplasms: the St Jude experience.","volume":"63","author":"Fuller","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R129-2-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/path.837","article-title":"Subtyping of oligo-astrocytic tumours by comparative genomic hybridization.","volume":"194","author":"Jeuken","year":"2001","journal-title":"J Pathol"},{"key":"R130-2-20210202","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00005072-199710000-00003","article-title":"Molecular genetic evidence for subtypes of oligoastrocytomas.","volume":"56","author":"Maintz","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R131-2-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)64183-1","article-title":"Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.","volume":"161","author":"Mueller","year":"2002","journal-title":"Am J Pathol"},{"key":"R132-2-20210202","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/hupa.2002.124784","article-title":"Clonality of oligoastrocytomas.","volume":"33","author":"Dong","year":"2002","journal-title":"Hum Pathol"},{"key":"R133-2-20210202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ana.10405","article-title":"Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.","volume":"52","author":"Bissola","year":"2002","journal-title":"Ann Neurol"},{"key":"R134-2-20210202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-4608(89)90192-1","article-title":"A cytogenetic study of 53 human gliomas.","volume":"39","author":"Jenkins","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"R135-2-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-4608(92)90085-M","article-title":"Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma.","volume":"61","author":"Weremowicz","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"R136-2-20210202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/gcc.2870130407","article-title":"Molecular analysis of genetic changes in ependymomas.","volume":"13","author":"Bijlsma","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"R137-2-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-4608(94)00148-5","article-title":"Involvement of chromosome 22 in ependymomas.","volume":"79","author":"Wernicke","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"R138-2-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-4608(00)00265-X","article-title":"Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas.","volume":"122","author":"Zheng","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"R139-2-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/gcc.1167","article-title":"Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridization in paediatric ependymoma.","volume":"32","author":"Ward","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R140-2-20210202","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64061-8","article-title":"Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.","volume":"158","author":"Hirose","year":"2001","journal-title":"Am J Pathol"},{"key":"R141-2-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.1086","article-title":"Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.","volume":"197","author":"Jeuken","year":"2002","journal-title":"J Pathol"},{"key":"R142-2-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6600180","article-title":"Genetic abnormalities detected in ependymomas by comparative genomic hybridization.","volume":"83","author":"Carter","year":"2002","journal-title":"Br J Cancer"},{"key":"R143-2-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00006123-199607000-00026","article-title":"Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.","volume":"39","author":"Birch","year":"1996","journal-title":"Neurosurgery"},{"key":"R144-2-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<37::AID-GCC6>3.0.CO;2-3","article-title":"Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.","volume":"17","author":"von Haken","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R145-2-20210202","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9440(10)65158-9","article-title":"Molecular genetic analysis of ependymal tumors: NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.","volume":"155","author":"Ebert","year":"1999","journal-title":"Am J Pathol"},{"key":"R146-2-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-4608(00)00262-4","article-title":"Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.","volume":"121","author":"Rosseau-Merck","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"R147-2-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1134>3.0.CO;2-P","article-title":"Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.","volume":"91","author":"Lamszus","year":"2001","journal-title":"Int J Cancer"},{"key":"R148-2-20210202","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1038\/sj.onc.1202258","article-title":"Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain, and breast.","volume":"17","author":"Tran","year":"1998","journal-title":"Oncogene"},{"key":"R149-2-20210202","first-page":"35","article-title":"A novel member of the FN2\/ERM\/4.1 superfamily with growth suppressing properties in lung cancer.","volume":"59","author":"Tran","year":"1999","journal-title":"Cancer Res"},{"key":"R150-2-20210202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/modpathol.3880558","article-title":"Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.","volume":"15","author":"Singh","year":"2002","journal-title":"Mod Pathol"},{"key":"R151-2-20210202","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.3800390","article-title":"Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.","volume":"18","author":"Rajaram","year":"2005","journal-title":"Mod Pathol"},{"key":"R152-2-20210202","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<230::AID-GCC8>3.0.CO;2-C","article-title":"Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.","volume":"24","author":"Reardon","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"R153-2-20210202","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0002-9440(10)64491-4","article-title":"Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.","volume":"161","author":"Dyer","year":"2002","journal-title":"Am J Pathol"},{"key":"R154-2-20210202","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199707000-00010","article-title":"Clear cell ependymoma: a mimic of oligodendroglioma: clinicopathologic and ultrastructural considerations.","volume":"21","author":"Min","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R155-2-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3171\/jns.2000.93.4.0605","article-title":"Prognostic factors in intracranial ependymomas in children.","volume":"93","author":"Figarella-Branger","year":"2000","journal-title":"J Neurosurg"},{"key":"R156-2-20210202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0360-3016(01)02801-2","article-title":"Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.","volume":"53","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R157-2-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1096-911X(199708)29:2<79::AID-MPO3>3.0.CO;2-O","article-title":"Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group.","volume":"29","author":"Perilongo","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R158-2-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00381-003-0753-x","article-title":"Ependymoma.","volume":"19","author":"Teo","year":"2003","journal-title":"Childs Nerv Syst"},{"key":"R159-2-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00006123-199904000-00018","article-title":"Supratentorial ependymomas in adult patients.","volume":"44","author":"Schwartz","year":"1999","journal-title":"Neurosurgery"},{"key":"R160-2-20210202","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.20075","article-title":"The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.","volume":"100","author":"Korshunov","year":"2003","journal-title":"Cancer"},{"key":"R161-2-20210202","first-page":"3054","article-title":"ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.","volume":"8","author":"Gilbertson","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R162-2-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-4608(96)00319-6","article-title":"Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.","volume":"97","author":"Burnett","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"R163-2-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","article-title":"Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.","volume":"86","author":"Russo","year":"1999","journal-title":"Cancer"},{"key":"R164-2-20210202","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.bjc.6690525","article-title":"Comparative genomic hybridization and histologic variation in primitive neuroectodermal tumours.","volume":"80","author":"Nicholson","year":"1999","journal-title":"Br J Cancer"},{"key":"R165-2-20210202","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00000478-199809000-00007","article-title":"Atypical teratoid \/ rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma.","volume":"22","author":"Burger","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R166-2-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3171\/jns.1996.85.1.0056","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood: definition of an entity.","volume":"85","author":"Rorke","year":"1996","journal-title":"J Neurosurg"},{"key":"R167-2-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2990.2002.00419.x","article-title":"Classifying the medulloblastoma: insights from morphology and molecular genetics.","volume":"28","author":"Ellison","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R168-2-20210202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000071316","article-title":"Medulloblastoma: present concepts of stratification into risk groups.","volume":"39","author":"Packer","year":"2003","journal-title":"Pediatr Neurosurg"},{"key":"R169-2-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnen\/63.5.441","article-title":"Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.","volume":"63","author":"Eberhart","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R170-2-20210202","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1200\/JCO.2004.06.032","article-title":"Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.","volume":"22","author":"Gajjar","year":"2004","journal-title":"J Clin Oncol"},{"key":"R171-2-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00000478-199207000-00007","article-title":"Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.","volume":"16","author":"Giangaspero","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R172-2-20210202","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/jns.1999.91.6.0971","article-title":"Medulloblastoma with extensive nodularity: a variant with favorable prognosis.","volume":"91","author":"Giangaspero","year":"1999","journal-title":"J Neurosurg"},{"key":"R173-2-20210202","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1054\/bjoc.2001.1987","article-title":"Clinical and molecular stratification of disease risk in medulloblastoma.","volume":"85","author":"Gilbertson","year":"2001","journal-title":"Br J Cancer"},{"key":"R174-2-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnen\/59.10.857","article-title":"Large cell\/anaplastic medulloblastomas: a Pediatric Oncology Group study.","volume":"59","author":"Brown","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"R175-2-20210202","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00006123-200010000-00020","article-title":"Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: A review.","volume":"47","author":"Taylor","year":"2000","journal-title":"Neurosurgery"},{"key":"R176-2-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/gcc.2870010206","article-title":"Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system.","volume":"1","author":"Biegel","year":"1989","journal-title":"Genes Chromosomes Cancer"},{"key":"R177-2-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1750-3639.1990.tb00633.x","article-title":"Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma.","volume":"1","author":"Bigner","year":"1990","journal-title":"Brain Pathol"},{"key":"R178-2-20210202","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00381-002-0617-9","article-title":"Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma.","volume":"18","author":"DeChiara","year":"2002","journal-title":"Childs Nerv Syst"},{"key":"R179-2-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0165-4608(92)90150-7","article-title":"Cytogenetic analysis of 39 pediatric central nervous system tumors.","volume":"59","author":"Karnes","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"R180-2-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3346\/jkms.2000.15.4.452","article-title":"The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma.","volume":"15","author":"Nam","year":"2000","journal-title":"J Korean Med Sci"},{"key":"R181-2-20210202","first-page":"473","article-title":"Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.","volume":"3","author":"Biegel","year":"1997","journal-title":"Clin Cancer Res"},{"key":"R182-2-20210202","first-page":"1559","article-title":"Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.","volume":"2","author":"Emandian","year":"1996","journal-title":"Clin Cancer Res"},{"key":"R183-2-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000120605","article-title":"Prognostic significance of molecular genetic markers in childhood brain tumors.","volume":"17","author":"Cogen","year":"1991","journal-title":"Pediatr Neurosurg"},{"key":"R184-2-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01052657","article-title":"Prognostic implications of chromosome 17p deletions in human medulloblastomas.","volume":"24","author":"Batra","year":"1995","journal-title":"J Neurooncol"},{"key":"R185-2-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/B:NEON.0000021773.71127.fb","article-title":"Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.","volume":"67","author":"Jung","year":"2004","journal-title":"J Neurooncol"},{"key":"R186-2-20210202","first-page":"4042","article-title":"Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.","volume":"57","author":"Reardon","year":"1997","journal-title":"Cancer Res"},{"key":"R187-2-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/geno.1994.1481","article-title":"Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.","volume":"23","author":"McDonald","year":"1994","journal-title":"Genomics"},{"key":"R188-2-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0","article-title":"High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2.","volume":"18","author":"Scheurlen","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"R189-2-20210202","first-page":"3391","article-title":"Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.","volume":"52","author":"Biegel","year":"1992","journal-title":"Cancer Res"},{"key":"R190-2-20210202","first-page":"3794","article-title":"Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.","volume":"62","author":"Rood","year":"2002","journal-title":"Cancer Res"},{"key":"R191-2-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/geno.1999.5864","article-title":"Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus.","volume":"59","author":"Smith","year":"1999","journal-title":"Genomics"},{"key":"R192-2-20210202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1750-3639.2002.tb00420.x","article-title":"Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell\/anaplastic medulloblastomas.","volume":"12","author":"Eberhart","year":"2002","journal-title":"Brain Pathol"},{"key":"R193-2-20210202","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncr.10189","article-title":"Histopathologic grading of medulloblastomas: A Pediatric Oncology Group study.","volume":"94","author":"Eberhart","year":"2002","journal-title":"Cancer"},{"key":"R194-2-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3171\/jns.2001.95.1.0082","article-title":"Large cell\/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.","volume":"95","author":"Leonard","year":"2001","journal-title":"J Neurosurg"},{"key":"R195-2-20210202","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1200\/JCO.1998.16.7.2478","article-title":"Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.","volume":"16","author":"Scheurlen","year":"1998","journal-title":"J Clin Oncol"},{"key":"R196-2-20210202","first-page":"5649","article-title":"p53 gene mutations and mdm2 gene amplification are uncommon in medulloblastoma.","volume":"54","author":"Adesina","year":"1994","journal-title":"Cancer Res"},{"key":"R197-2-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0344-0338(00)80073-4","article-title":"Expression of p27kip1 and p53 in medulloblastoma: relationship with cell proliferation and survival.","volume":"196","author":"Adesina","year":"2000","journal-title":"Pathol Res Pract"},{"key":"R198-2-20210202","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.1993.431","article-title":"p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.","volume":"68","author":"Jaros","year":"1993","journal-title":"Br J Cancer"},{"key":"R199-2-20210202","first-page":"3272","article-title":"Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.","volume":"57","author":"Gilbertson","year":"1997","journal-title":"Cancer Res"},{"key":"R200-2-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/bjc.1995.96","article-title":"Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.","volume":"71","author":"Gilbertson","year":"1995","journal-title":"Br J Cancer"},{"key":"R201-2-20210202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00043426-199711000-00004","article-title":"Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children.","volume":"19","author":"Herms","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"R202-2-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000028932","article-title":"Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.","volume":"32","author":"Reardon","year":"2000","journal-title":"Pediatr Neurosurg"},{"key":"R203-2-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5858\/2002-126-0540-MAMOAI","article-title":"MYCC and MYCN oncogene amplification in medulloblastoma: a fluorescence in situ hybridization study on paraffin sections from the Childrens Oncology Group.","volume":"126","author":"Aldosari","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R204-2-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/030089169107700205","article-title":"N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification.","volume":"77","author":"Badiali","year":"1991","journal-title":"Tumori"},{"key":"R205-2-20210202","first-page":"2425","article-title":"MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor\/medulloblastoma.","volume":"7","author":"Grotzer","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R206-2-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0215(20000920)89:5<395::AID-IJC1>3.0.CO;2-V","article-title":"C-myc expression in medulloblastoma and its prognostic value.","volume":"89","author":"Herms","year":"2000","journal-title":"Int J Cancer"},{"key":"R207-2-20210202","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2000.18.5.1027","article-title":"TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.","volume":"18","author":"Grotzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"R208-2-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1016226319068","article-title":"Immunohistochemical markers for prognosis of average-risk pediatric medulloblastomas. The effect of apoptotic index, TrkC, and c-myc expression.","volume":"58","author":"Korshunov","year":"2002","journal-title":"J Neurooncol"},{"key":"R209-2-20210202","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3171\/jns.2001.94.5.0799","article-title":"Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas.","volume":"94","author":"Yin","year":"2001","journal-title":"J Neurosurg"},{"key":"R210-2-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0997-32","article-title":"DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.","volume":"17","author":"Mollenhauer","year":"1997","journal-title":"Nat Genet"},{"key":"R211-2-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000065107","article-title":"Atypical teratoid\/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features.","volume":"37","author":"Bambakidis","year":"2002","journal-title":"Pediatr Neurosurg"},{"key":"R212-2-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00043426-200206000-00004","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: report on workshop.","volume":"24","author":"Packer","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R213-2-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01052653","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood.","volume":"24","author":"Rorke","year":"1995","journal-title":"J Neurooncol"},{"key":"R214-2-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y","article-title":"Narrowing the critical region for a rhabdoid tumor locus in 22q11.","volume":"16","author":"Biegel","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R215-2-20210202","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/8.13.2359","article-title":"Spectrum of hSNF5\/INI1 somatic mutations in human cancer and genotype-phenotype correlations.","volume":"8","author":"Sevenet","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R216-2-20210202","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/hupa.2001.28252","article-title":"Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?","volume":"32","author":"Fuller","year":"2001","journal-title":"Hum Pathol"},{"key":"R217-2-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/hupa.2001.21572","article-title":"A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid\/rhabdoid tumors from medulloblastoma\/central primitive neuroectodermal tumors.","volume":"32","author":"Bruch","year":"2001","journal-title":"Hum Pathol"},{"key":"R218-2-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer.","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"R219-2-20210202","first-page":"3461","article-title":"Alterations of the hSNF5\/INI1 gene in central nervous system atypical teratoid\/rhabdoid tumors and renal and extrarenal rhabdoid tumors.","volume":"8","author":"Biegel","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R220-2-20210202","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1038\/sj.onc.1205841","article-title":"A key role of the hSNF5\/INI1 tumor suppressor in the control of the G1-S transition of the cell cycle.","volume":"21","author":"Versteege","year":"2002","journal-title":"Oncogene"},{"key":"R221-2-20210202","first-page":"3152","article-title":"hSNF5\/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.","volume":"59","author":"Rousseau-Merck","year":"1999","journal-title":"Cancer Res"},{"key":"R222-2-20210202","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1086\/302639","article-title":"Constitutional mutations of the hSNF5\/INI1 gene predispose to a variety of cancers.","volume":"65","author":"Sevenet","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R223-2-20210202","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res"},{"key":"R224-2-20210202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2990.2002.00388.x","article-title":"Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5\/INI1 tumour suppressor gene.","volume":"28","author":"Kraus","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R225-2-20210202","first-page":"2759","article-title":"Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.","volume":"6","author":"Biegel","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R226-2-20210202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004010000316","article-title":"Mutational analysis if INI1 in sporadic human brain tumors.","volume":"101","author":"Weber","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"R227-2-20210202","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1200\/JCO.2005.05.187","article-title":"Atypical teratoid\/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.","volume":"23","author":"Tekautz","year":"2005","journal-title":"J Clin Oncol"},{"key":"R228-2-20210202","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000478-200405000-00013","article-title":"Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms.","volume":"28","author":"Judkins","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R229-2-20210202","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/01.pas.0000141390.14548.34","article-title":"Immunohistochemical analysis of hSNF5\/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.","volume":"28","author":"Hoot","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R230-2-20210202","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/modpathol.3800375","article-title":"INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.","volume":"18","author":"Perry","year":"2005","journal-title":"Mod Pathol"},{"key":"R231-2-20210202","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","article-title":"Meningioma grading; an analysis of histologic parameters.","volume":"21","author":"Perry","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R232-2-20210202","first-page":"2046","article-title":"Malignancy in meningiomas: a clinicopathologic study of 116 patients, with grading implications.","volume":"85","author":"Perry","year":"1999","journal-title":"Cancer"},{"key":"R233-2-20210202","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jnen\/59.10.872","article-title":"Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases.","volume":"59","author":"Perry","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"R234-2-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0344-0338(00)80050-3","article-title":"Correlation between histologic grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.","volume":"196","author":"Lanzafame","year":"2000","journal-title":"Pathol Res Pract"},{"key":"R235-2-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/jns.2004.100.2.0303","article-title":"Prognostic value of allelic losses and telomerase activity in meningiomas.","volume":"100","author":"Leuraud","year":"2004","journal-title":"J Neurosurg"},{"key":"R236-2-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas.","volume":"70","author":"Perry","year":"2004","journal-title":"J Neurooncol"},{"key":"R237-2-20210202","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnen\/60.10.994","article-title":"Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.","volume":"60","author":"Perry","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R238-2-20210202","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat Genet"},{"key":"R239-2-20210202","first-page":"5995","article-title":"Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.","volume":"59","author":"Ueki","year":"1999","journal-title":"Cancer Res"},{"key":"R240-2-20210202","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnen\/59.6.504","article-title":"Allelic losses in neurofibromatosis 2-associated meningiomas.","volume":"59","author":"Lamszus","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"R241-2-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.49.1.267","article-title":"Loss of merlin expression in sporadic meningiomas, ependymomas, and schwannomas.","volume":"49","author":"Gutmann","year":"1997","journal-title":"Neurology"},{"key":"R242-2-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/nbdi.2000.0376","article-title":"The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion.","volume":"8","author":"Gutmann","year":"2001","journal-title":"Neurobiol Dis"},{"key":"R243-2-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0969-9961(03)00071-8","article-title":"Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis.","volume":"13","author":"Robb","year":"2003","journal-title":"Neurobiol Dis"},{"key":"R244-2-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/9.10.1495","article-title":"Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.","volume":"9","author":"Gutmann","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R245-2-20210202","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jnen\/63.10.1015","article-title":"Loss of Tumor Suppressor in Lung Cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.","volume":"63","author":"Surace","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R246-2-20210202","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14 q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.","volume":"60","author":"Cai","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R247-2-20210202","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: towards a genetic model of meningioma progression.","volume":"94","author":"Weber","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R248-2-20210202","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas.","volume":"159","author":"Bostrom","year":"2001","journal-title":"Am J Pathol"},{"key":"R249-2-20210202","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1200\/JCO.2003.07.156","article-title":"New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.","volume":"21","author":"Maillo","year":"2003","journal-title":"J Clin Oncol"},{"key":"R250-2-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0046-8177(97)90149-0","article-title":"Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.","volume":"28","author":"Tse","year":"1997","journal-title":"Hum Pathol"},{"key":"R251-2-20210202","first-page":"53","article-title":"comparative genomic hybridization analysis of genomic alterations in benign, atypical, and anaplastic meningiomas.","volume":"102","author":"Arslantas","year":"2002","journal-title":"Acta Neurol Belg"},{"key":"R252-2-20210202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-4608(03)00279-6","article-title":"Association of loss of 1p and alterations of chromosome 14 in meningioma progression.","volume":"148","author":"Lopez-Gines","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"R253-2-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-4608(02)00653-2","article-title":"A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression.","volume":"140","author":"Murakami","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"R254-2-20210202","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.humpath.2004.07.017","article-title":"Anaplastic meningioma vs. meningeal hemangiopericytoma: Immunohistochemical and genetic markers.","volume":"35","author":"Rajaram","year":"2004","journal-title":"Hum Pathol"},{"key":"R255-2-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1013863630293","article-title":"Alterations of INK4ap16-p14\/ARF\/INK4bp15 expression and telomerase activation in meningioma progression.","volume":"55","author":"Simon","year":"2001","journal-title":"J Neurooncol"},{"key":"R256-2-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.","volume":"12","author":"Perry","year":"2002","journal-title":"Brain Pathol"},{"key":"R257-2-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/FVNU-7UBY-DXE3-77MT","article-title":"PS6K amplification characterizes a small subset of anaplastic meningiomas.","volume":"115","author":"Cai","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R258-2-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1750-3639.2002.tb00429.x","article-title":"Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas.","volume":"12","author":"Buschges","year":"2002","journal-title":"Brain Pathol"},{"key":"R259-2-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.20201","article-title":"Functional significance of S6K overexpression in meningioma progression.","volume":"56","author":"Surace","year":"2004","journal-title":"Ann Neurol"},{"key":"R260-2-20210202","first-page":"4443","article-title":"Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.","volume":"9","author":"Mihaila","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.pap.0000175117.47918.f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:59:00Z","timestamp":1785855540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00125480-200507000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":259,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pap.0000175117.47918.f7","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}